JPH01502027A - 3’―アジド―2’,3’―ジデオキシウリジン抗レトロウィルス組成物 - Google Patents
3’―アジド―2’,3’―ジデオキシウリジン抗レトロウィルス組成物Info
- Publication number
- JPH01502027A JPH01502027A JP63501551A JP50155188A JPH01502027A JP H01502027 A JPH01502027 A JP H01502027A JP 63501551 A JP63501551 A JP 63501551A JP 50155188 A JP50155188 A JP 50155188A JP H01502027 A JPH01502027 A JP H01502027A
- Authority
- JP
- Japan
- Prior art keywords
- azido
- dideoxyuridine
- compound
- trityl
- tables
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Abstract
Description
Claims (24)
- 1.次の構造式を有する化合物またはその薬理学的に受容され得る塩を,HIV を阻害し得る量で,薬学的に受容され得るキャリアと組み合わせて含有する薬剤 組成物:▲数式、化学式、表等があります▼ ここで,RIはOH,モノホスフェート,ジホスフェートまたはトリホスフェー トである。
- 2.前記薬学的に受容され得るキャリアにより,前記化合物が体内から急速に排 出されるのが防止される,請求の範囲第1項に記載の薬剤組成物。
- 3.前記薬学的に受容され得るキャリアがリボソーム懸濁液を包含する請求の範 囲第1項に記載の薬剤組成物。
- 4.R1がモノホスフェート,ジホスフェートまたはトリホスフェートである請 求の範囲第3項に記載の薬剤組成物。
- 5.R1がモノホスフェート,ジホスフェートまたはトリホスフェートである請 求の範囲第1項に記載の薬剤組成物。
- 6.R1がOHである請求の範囲第1項に記載の薬剤組成物。
- 7.前記化合物が,HIV逆転写酵素を阻害し得る量で含有される,請求の範囲 第1項に記載の薬剤組成物。
- 8.前記化合物が,ヒトDNAポリメラーゼを阻害しない量で含有される,請求 の範囲第7項に記載の薬剤組成物。
- 9.ヒトにおいてHIVを処置し,そしてHIV感染を防止する方法であって, 該方法は,HIVに感染したヒトに,次の構造式を有する化合物またはその薬理 学的に受容され得る塩をHIVを阻害し得る量で,薬学的に受容され得るキャリ アと組み合わせて投与することを包含する: ▲数式、化学式、表等があります▼ ここで,R1はOH,モノホスフェート,ジホスフェートまたはトリホスフェー トである。
- 10.前記化合物が体内から急速に排出されるのが保護される,請求の範囲第9 項に記載の方法。
- 11.前記薬学的に受容され得るキャリアがリボソーム懸濁液を包含する請求の 範囲第9項に記載の方法。
- 12.RIがモノホスフェート,ジホスフェートまたはトリホスフェートである 請求の範囲第11項に記載の方法。
- 13.RIがモノホスフェート,ジホスフェートまたはトリホスフェートである 請求の範囲第9項に記載の方法。
- 14.RIがOHである請求の範囲第9項に記載の方法。
- 15.前記化合物を,HIV逆転写酵素を阻害し得る量で投与することを包含す る,請求の範囲第9項に記載の方法。
- 16.ヒトDNAポリメラーゼを阻害しない量で前記化合物を投与することを包 含する請求の範囲第15項に記載の方法。
- 17.ウィルス性疾患を処置するための組成物を調製するための方法であって, 該方法は,3′−アジド−2′,3′−ジデオキシウリジンを,患者の血液中の 濃度が約0.2〜40umとなるような量で投与すること,を包含する。
- 18.さらに,前記3′−アジド−2−,3′−ジデオキシウリジンの合成を包 含する請求の範囲第17項の方法であって,該合成は,2′−デオキシウリジン とトリチルクロリドとを反応させて5′−O−トリチル−2′−デオキシウリジ ンを調製し,該5′−O−トリチル−2′−デオキシウリジンにメシルクロリド を反応させて3′−O−メシル−5′−トリチル−2′−デオキシウリジンを調 製し,該3′−O−メシル−5′−トリチル−2′−デオキシウリジンをアルカ リ条件下で還流して2,3′−アンヒドロ−5′−O−トリチル−2′−デオキ シウリジンを得,リチウムアジドを2,3′−アンヒドロ−5′−O−トリチル ー2′−デオキシウリジンに反応させて3′−アジド−5′−O−トリチル−2 ′,3′−ジデオキシウリジンを調製し,該3′−アジド−5′−0−トリチル ー2′,3′−ジデオキシウリジンを酢酸中で加熱することにより行われる。
- 19.前記3′−アジド−2′,3′−ジデオキシウリジンを,薬学的に受容さ れ得る腸溶剤皮としてのキャリアでカプセル化することを包含する,請求の範囲 第17項に記載の方法。
- 20.前記3′−アジド−2′,3′−ジデオキシウリジンを生物分解性移植物 中にカプセル化することをさらに包含する,請求の範囲第17項に記載の方法。
- 21.3間−アジド−2′,3′−ジデオキシウリジンの供給にリボソーム懸濁 液を使用することをさらに包含する,請求の範囲第17項に記載の方法。
- 22.3′−アジド−2′,3′−ジデオキシウリジンをリン酸化し,モノ,ジ またはトリホスフェートを形成することをさらに包含する,請求の範囲第17項 に記載の方法。
- 23.前記3′−アジド−2′,3′−ジデオキシウリジンをアセチル化するこ とをさらに包含する,請求の範囲第17項に記載の方法。
- 24.注射用の水,生理食塩水,油,ポリエチレングリコール,グリセリン.プ ロピレングリコール,抗菌剤,抗酸化剤,キレート剤,キレート剤,および等張 性を調整するための緩衝剤でなる群から選択される化合物を,該3′−アジド− 2′,3′−ジデオキシウリジンと混合することを包含する,請求の範囲第17 項に記載の方法。 表1▲数式、化学式、表等があります▼表2▲数式、化学式、表等があります▼ 表5▲数式、化学式、表等があります▼表3▲数式、化学式、表等があります▼ 表4▲数式、化学式、表等があります▼表6▲数式、化学式、表等があります▼ 発明の詳細な説明
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US747387A | 1987-01-28 | 1987-01-28 | |
US07/104,438 US4916122A (en) | 1987-01-28 | 1987-10-02 | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition |
PCT/US1988/000073 WO1988005657A1 (en) | 1987-01-28 | 1988-01-13 | 3'-azido-2',3'-dideoxyuridine anti-retroviral composition |
US7473 | 1993-01-22 | ||
US104438 | 1993-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01502027A true JPH01502027A (ja) | 1989-07-13 |
JPH0649652B2 JPH0649652B2 (ja) | 1994-06-29 |
Family
ID=26677039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63501551A Expired - Lifetime JPH0649652B2 (ja) | 1987-01-28 | 1988-01-13 | 3’―アジド―2’,3’―ジデオキシウリジン抗レトロウィルス組成物 |
Country Status (14)
Country | Link |
---|---|
US (1) | US4916122A (ja) |
EP (1) | EP0301064B1 (ja) |
JP (1) | JPH0649652B2 (ja) |
AR (1) | AR240251A1 (ja) |
AT (1) | ATE110271T1 (ja) |
AU (1) | AU606391B2 (ja) |
BR (1) | BR8804823A (ja) |
CA (1) | CA1313498C (ja) |
DE (1) | DE3851187D1 (ja) |
ES (1) | ES2009168A6 (ja) |
IL (1) | IL85078A0 (ja) |
MX (1) | MX167702B (ja) |
PT (1) | PT86648B (ja) |
WO (1) | WO1988005657A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997006179A1 (fr) * | 1995-08-04 | 1997-02-20 | Kobayashi Perfumery Co., Ltd. | Procede permettant de produire des derives d'azidonucleoside |
JP2010280724A (ja) * | 1998-06-24 | 2010-12-16 | Emory Univ | Hivの治療薬物の製造のための他の抗hiv薬と組み合わせた3’−アジド−2’,3’−ジデオキシウリジンの使用 |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084445A (en) * | 1986-05-01 | 1992-01-28 | University Of Georgia Research Foundation, Inc. | 3'-azido-2',3'-dideoxy-5-methylcytidine |
US5190926A (en) * | 1987-01-28 | 1993-03-02 | University Of Georgia Research Foundation, Inc. | 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents |
US5159067A (en) * | 1987-01-28 | 1992-10-27 | University Of Georgia Research Foundation Inc. | 5'-Diphosphohexose nucleoside pharmaceutical compositions |
JPH03501253A (ja) * | 1987-09-22 | 1991-03-22 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | エイズ(aids)治療を目的とするリポソームによるヌクレオシド類似物質 |
US5631370A (en) * | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
US5175292A (en) * | 1988-01-20 | 1992-12-29 | Regents Of The University Of Minnesota | Intermediates for the preparation of dideoxycarbocyclic nucleosides |
US5122517A (en) * | 1988-06-10 | 1992-06-16 | Regents Of The University Of Minnesota | Antiviral combination comprising nucleoside analogs |
US6911470B1 (en) | 1988-09-22 | 2005-06-28 | Raymond F. Schinazi | Polyoxometalate compounds as antiviral agents |
FR2640508B1 (fr) * | 1988-12-19 | 1994-07-01 | Dietlin Francois | Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire |
US5118672A (en) * | 1989-07-10 | 1992-06-02 | University Of Georgia Research Foundation | 5'-diphosphohexose nucleoside pharmaceutical compositions |
SE464168B (sv) * | 1989-07-19 | 1991-03-18 | Bo Fredrik Oeberg | Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) |
FR2653771B1 (fr) * | 1989-10-27 | 1994-09-23 | Univ Paris Curie | Procede de preparation de l'azt (azido-3'-desoxy-3'-thymidine) et de composes apparentes. |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
US5914331A (en) * | 1990-02-01 | 1999-06-22 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US6069252A (en) * | 1990-02-01 | 2000-05-30 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
US5583000A (en) * | 1991-09-03 | 1996-12-10 | The Regents Of The University Of California | Protease-binding compounds and methods of use |
FI90552C (fi) * | 1991-10-09 | 1994-02-25 | Leiras Oy | Menetelmä nukleosidijohdannaisten valmistamiseksi |
US6008045A (en) * | 1991-11-15 | 1999-12-28 | Board Of Trustees Of The Leland Stanford University | Nucleic acid encoding human DNA polymerase α |
US20050192299A1 (en) * | 1992-04-16 | 2005-09-01 | Yung-Chi Cheng | Method of treating or preventing hepatitis B virus |
AU7954694A (en) | 1993-09-10 | 1995-03-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis b virus activity |
US20020120130A1 (en) * | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
IL115156A (en) * | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US5824706A (en) * | 1994-09-26 | 1998-10-20 | Schinazi; Raymond F. | Method, compositions, and apparatus for treating and preventing respiratory viral infections |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
PT831852E (pt) * | 1995-06-07 | 2007-02-28 | Uab Research Foundation | Nucleósidos com actividade anti-vírus da hepatite b |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
AU5475799A (en) | 1998-08-10 | 2000-03-06 | Centre National De La Recherche Scientifique | Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis |
JP2002528554A (ja) | 1998-11-05 | 2002-09-03 | サントル・ナシオナル・ドウ・ラ・ルシエルシユ・シアンテイフイク | B型肝炎ウイルス活性を持ったヌクレオシド |
US6407077B1 (en) | 1998-11-05 | 2002-06-18 | Emory University | β-L nucleosides for the treatment of HIV infection |
US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
US6787526B1 (en) | 2000-05-26 | 2004-09-07 | Idenix Pharmaceuticals, Inc. | Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
US6875751B2 (en) * | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
SE521676C2 (sv) * | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
TWI244393B (en) * | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
ES2547002T3 (es) * | 2002-09-13 | 2015-09-30 | Novartis Ag | Beta-L-2' desoxinucleósidos para el tratamiento de cepas de VHB resistentes |
JP5504179B2 (ja) | 2008-03-03 | 2014-05-28 | トスク インコーポレーティッド | 毒性を低減するためのメトトレキセートアジュバントおよびその使用法 |
PA8852101A1 (es) * | 2008-12-08 | 2010-07-27 | Medivir Ab | Nucleótidos uracil ciclopropílicos |
CN114276359B (zh) * | 2022-01-05 | 2023-05-05 | 浙江大学 | 一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3282921A (en) * | 1964-06-04 | 1966-11-01 | Syntex Corp | Halo-deoxynucleosides and processes for the preparation thereof |
US3755295A (en) * | 1969-10-24 | 1973-08-28 | Syntex Corp | 1-(2-amino-2-deoxy-{62 -d-ribofuranosyl) pyrimidines and derivatives thereof |
US3775397A (en) * | 1969-11-12 | 1973-11-27 | Akad Wissenschaften Ddr | Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides |
US3687931A (en) * | 1970-03-19 | 1972-08-29 | Syntex Corp | Halogenated purine and pyrimidine nucleosides and process therefor |
US3817982A (en) * | 1971-12-29 | 1974-06-18 | Syntex Inc | 2{40 ,3{40 -unsaturated nucleosides and method of making |
DE2627076A1 (de) * | 1976-06-16 | 1977-12-29 | Max Planck Gesellschaft | Mittel zur inhibierung des zellwachstums |
US4071680A (en) * | 1976-12-20 | 1978-01-31 | Hoffmann-La Roche Inc. | 5'-Deoxy-5-fluoropyrimidine nucleosides |
US4093715A (en) * | 1977-04-28 | 1978-06-06 | Research Corporation | 5-Iodo-5'-amino-2',5'-dideoxycytidine and the pharmaceutically acceptable salts thereof |
US4128639A (en) * | 1977-12-14 | 1978-12-05 | Research Corporation | Nitrosourea analogs of thymidine |
US4210638A (en) * | 1978-03-17 | 1980-07-01 | Pcr, Inc. | Antiviral composition and method of treating virus diseases |
US4230698A (en) * | 1978-05-12 | 1980-10-28 | Research Corporation | 2-Substituted arabinofuranosyl nucleosides and nucleotides |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4604382A (en) * | 1983-01-17 | 1986-08-05 | Research Corporation | 3'-amino-2',3'-dideoxycytidine and the pharmacologically acceptable salts thereof |
US4540566A (en) * | 1984-04-02 | 1985-09-10 | Forest Laboratories, Inc. | Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose |
DD224490A1 (de) * | 1984-04-30 | 1985-07-10 | Adw Ddr | Verfahren zur herstellung eines virostatischen mittels |
GB8523881D0 (en) | 1985-09-27 | 1985-10-30 | Wellcome Found | Antiviral compounds |
DE3650492T2 (de) * | 1985-03-16 | 1996-10-31 | Wellcome Found | Therapeutische Nukleoside |
GB8506869D0 (en) | 1985-03-16 | 1985-04-17 | Wellcome Found | Antiviral compound |
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
DE3687069T2 (de) * | 1985-03-16 | 1993-03-25 | Wellcome Found | Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen. |
GB8506868D0 (en) | 1985-03-16 | 1985-04-17 | Wellcome Found | Antibacterial compound |
GB8511774D0 (en) | 1985-05-09 | 1985-06-19 | Wellcome Found | Antiviral compounds |
GB8511775D0 (en) | 1985-05-09 | 1985-06-19 | Wellcome Found | Antibacterial compounds |
GB8603450D0 (en) | 1986-02-12 | 1986-03-19 | Wellcome Found | Antiviral compounds |
GB8523878D0 (en) | 1985-09-27 | 1985-10-30 | Wellcome Found | Therapeutic compounds |
AU595832B2 (en) * | 1985-09-17 | 1990-04-12 | Wellcome Foundation Limited, The | Therapeutic nucleosides |
GB8603719D0 (en) | 1986-02-14 | 1986-03-19 | Wellcome Found | Antiviral compounds |
GB8608272D0 (en) | 1986-04-04 | 1986-05-08 | Wellcome Found | Antiviral combination |
GB8603447D0 (en) | 1986-02-12 | 1986-03-19 | Wellcome Found | Therapeutic compounds |
GB8615322D0 (en) | 1986-06-23 | 1986-07-30 | Wellcome Found | Antiviral combinations |
ZA867013B (en) * | 1985-09-17 | 1988-04-27 | Wellcome Found | Therapeutic nucleosides |
US4649161A (en) * | 1986-06-16 | 1987-03-10 | Massachusetts Institute Of Technology | Method for treating depression with d-fenfluramine |
US4710492A (en) * | 1986-06-23 | 1987-12-01 | Yale University | 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses |
-
1987
- 1987-10-02 US US07/104,438 patent/US4916122A/en not_active Expired - Lifetime
-
1988
- 1988-01-11 IL IL85078A patent/IL85078A0/xx unknown
- 1988-01-13 AU AU12426/88A patent/AU606391B2/en not_active Ceased
- 1988-01-13 BR BR8804823A patent/BR8804823A/pt not_active Application Discontinuation
- 1988-01-13 JP JP63501551A patent/JPH0649652B2/ja not_active Expired - Lifetime
- 1988-01-13 AT AT88901673T patent/ATE110271T1/de not_active IP Right Cessation
- 1988-01-13 EP EP88901673A patent/EP0301064B1/en not_active Expired - Lifetime
- 1988-01-13 DE DE3851187T patent/DE3851187D1/de not_active Expired - Lifetime
- 1988-01-13 WO PCT/US1988/000073 patent/WO1988005657A1/en active IP Right Grant
- 1988-01-26 MX MX010214A patent/MX167702B/es unknown
- 1988-01-27 CA CA000557486A patent/CA1313498C/en not_active Expired - Lifetime
- 1988-01-27 AR AR309938A patent/AR240251A1/es active
- 1988-01-28 ES ES8800241A patent/ES2009168A6/es not_active Expired
- 1988-01-28 PT PT86648A patent/PT86648B/pt not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997006179A1 (fr) * | 1995-08-04 | 1997-02-20 | Kobayashi Perfumery Co., Ltd. | Procede permettant de produire des derives d'azidonucleoside |
JP2010280724A (ja) * | 1998-06-24 | 2010-12-16 | Emory Univ | Hivの治療薬物の製造のための他の抗hiv薬と組み合わせた3’−アジド−2’,3’−ジデオキシウリジンの使用 |
Also Published As
Publication number | Publication date |
---|---|
BR8804823A (pt) | 1989-10-17 |
US4916122A (en) | 1990-04-10 |
EP0301064A1 (en) | 1989-02-01 |
AR240251A1 (es) | 1990-03-30 |
EP0301064B1 (en) | 1994-08-24 |
AU1242688A (en) | 1988-08-24 |
MX167702B (es) | 1993-04-06 |
AU606391B2 (en) | 1991-02-07 |
JPH0649652B2 (ja) | 1994-06-29 |
ATE110271T1 (de) | 1994-09-15 |
ES2009168A6 (es) | 1989-09-01 |
WO1988005657A1 (en) | 1988-08-11 |
PT86648B (pt) | 1991-02-08 |
DE3851187D1 (de) | 1994-09-29 |
PT86648A (pt) | 1988-02-01 |
IL85078A0 (en) | 1988-06-30 |
CA1313498C (en) | 1993-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH01502027A (ja) | 3’―アジド―2’,3’―ジデオキシウリジン抗レトロウィルス組成物 | |
US7589075B2 (en) | Use of an adenosine A3 receptor agonist for inhibition of viral replication | |
US5084445A (en) | 3'-azido-2',3'-dideoxy-5-methylcytidine | |
US5190926A (en) | 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents | |
EP0426785B1 (en) | Compositions and methods for treating viral infections | |
US5254539A (en) | Method of treating HIV with 2',3'-dideoxyinosine | |
CN101083997A (zh) | 用作抗hiv药剂的桦木醇衍生物 | |
WO2006031706A2 (en) | Betulinol derivatives as anti-hiv agents | |
JPH10507771A (ja) | L−エリトロシル ヌクレオシド | |
WO1992002530A1 (en) | Hexa-n-(o-hydroxybenzyl) neomycin b for inhibiting human retroviruses and for the treatment of aids | |
JPH11106395A (ja) | 新規な糖脂質、その製造方法及びその用途 | |
WO1997037661A1 (fr) | Medicament de prevention et de traitement des infections virales | |
US5077279A (en) | 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition | |
WO2002080856A2 (en) | Triaza compound immunoregulatory agents | |
US5026688A (en) | Novel AZT analogs | |
DE4320597A1 (de) | Verwendung von Polyphosphaten zur antiviralen Therapie und als Immunmodulatoren | |
US5026732A (en) | Use of avarone for the control of AIDS and ARC | |
JPS63264527A (ja) | 抗エイズウイルス剤 | |
JPH0438727B2 (ja) | ||
KR20190137080A (ko) | 싸이클로부틸 (s)-2-[[[(r)-2-(6-아미노퓨린-9-일)-1-메틸-에톡시]메틸-펜옥시-포스포릴]아미노]-프로파노에이트 및 이의 생산공정 및 응용 | |
AU3423989A (en) | Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections | |
JPH0436240A (ja) | 成人t細胞白血病治療剤 | |
DE3724951A1 (de) | Arzneimittel, enthaltend modifizierte desoxyribonukleinsaeure und dessen verwendung | |
JPH02304024A (ja) | エイズウィルス増殖抑制剤 | |
EP0351173A2 (en) | Substance having anti-retrovirus activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080629 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080629 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080629 Year of fee payment: 14 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080629 Year of fee payment: 14 |